Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,534,000 | 11,643,000 | 11,443,000 | 5,646,000 | 11,851,000 |
| Marketable Securities | N/A | N/A | N/A | 7,613,000 | N/A |
| Receivables | 4,492,000 | 4,482,000 | 4,326,000 | 4,376,000 | 4,253,000 |
| Inventories | 3,440,000 | 3,458,000 | 3,424,000 | 3,346,000 | 3,231,000 |
| Other current assets | 1,446,000 | 1,402,000 | 1,378,000 | 1,292,000 | 1,180,000 |
| TOTAL | $20,912,000 | $20,985,000 | $20,571,000 | $22,273,000 | $20,515,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 7,597,000 | N/A |
| Investments And Advances | 0 | 0 | 0 | 6,848,000 | 0 |
| Intangibles | 0 | 0 | 0 | 4,708,000 | 0 |
| Other Non-Current Assets | 27,004,000 | 26,250,000 | 26,526,000 | 7,891,000 | 25,814,000 |
| TOTAL | $27,004,000 | $26,250,000 | $26,526,000 | $27,044,000 | $25,814,000 |
| Total Assets | $47,916,000 | $47,235,000 | $47,097,000 | $49,317,000 | $46,329,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,616,000 | 2,883,000 | 3,399,000 | 2,779,000 | 2,582,000 |
| Accounts payable and accrued liabilities | 1,568,000 | 1,630,000 | 1,597,000 | 1,665,000 | 1,308,000 |
| Other current liabilities | 5,498,000 | 5,117,000 | 5,034,000 | 4,876,000 | 4,455,000 |
| TOTAL | $9,682,000 | $9,630,000 | $10,030,000 | $9,320,000 | $8,345,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,915,000 | 3,105,000 | 3,145,000 | 3,191,000 | 3,042,000 |
| Other Non-Current Liabilities | 6,402,000 | 6,185,000 | 6,159,000 | 3,155,000 | 6,362,000 |
| TOTAL | $9,316,000 | $9,307,000 | $9,300,000 | $9,478,000 | $9,446,000 |
| Total Liabilities | $18,998,000 | $18,937,000 | $19,330,000 | $18,798,000 | $17,791,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 1,017,000 | N/A |
| Retained earnings | N/A | N/A | N/A | 29,533,000 | N/A |
| Other shareholders' equity | 28,918,000 | 28,298,000 | 27,767,000 | 90,000 | 28,538,000 |
| TOTAL | $28,918,000 | $28,298,000 | $27,767,000 | $30,519,000 | $28,538,000 |
| Total Liabilities And Equity | $47,916,000 | $47,235,000 | $47,097,000 | $49,317,000 | $46,329,000 |